These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38913364)

  • 1. Evaluating COVID-19 Vaccines in the Era of Endemicity-Recency vs Reformulation.
    Mohan GS; Mina MJ; Ankomah PO
    JAMA Intern Med; 2024 Aug; 184(8):940-942. PubMed ID: 38913364
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    De Foo C; Grépin KA; Cook AR; Hsu LY; Bartos M; Singh S; Asgari N; Teo YY; Heymann DL; Legido-Quigley H
    Lancet; 2021 Oct; 398(10311):1547-1551. PubMed ID: 34619099
    [No Abstract]   [Full Text] [Related]  

  • 3. A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics.
    Borio LL; Bright RA; Emanuel EJ
    JAMA; 2022 Jan; 327(3):215-216. PubMed ID: 34989782
    [No Abstract]   [Full Text] [Related]  

  • 4. Universal Coronavirus Vaccines - An Urgent Need.
    Morens DM; Taubenberger JK; Fauci AS
    N Engl J Med; 2022 Jan; 386(4):297-299. PubMed ID: 34910863
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological characteristics govern the transition of COVID-19 to endemicity.
    Lavine JS; Bjornstad ON; Antia R
    Science; 2021 Feb; 371(6530):741-745. PubMed ID: 33436525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio Interview: Covid-19 as an Endemic Disease.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2022 Feb; 386(6):e21. PubMed ID: 35139281
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19: endemic doesn't mean harmless.
    Katzourakis A
    Nature; 2022 Jan; 601(7894):485. PubMed ID: 35075305
    [No Abstract]   [Full Text] [Related]  

  • 8. Transition to endemicity: Understanding COVID-19.
    Antia R; Halloran ME
    Immunity; 2021 Oct; 54(10):2172-2176. PubMed ID: 34626549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
    Joffe S
    JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID is here to stay: countries must decide how to adapt.
    Nature; 2022 Jan; 601(7892):165. PubMed ID: 35013606
    [No Abstract]   [Full Text] [Related]  

  • 11. Endemic infections, vaccinations, and variability of SARS-COV2 worldwide epidemiology: A cross-sectional study.
    Goswami RP; Ganguli B; Chatterjee M
    J Med Virol; 2021 May; 93(5):3105-3112. PubMed ID: 33580710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Omicron: what's next for COVID's viral evolution.
    Callaway E
    Nature; 2021 Dec; 600(7888):204-207. PubMed ID: 34876665
    [No Abstract]   [Full Text] [Related]  

  • 14. Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection.
    Xu W; Su S; Jiang S
    Clin Transl Med; 2021 Feb; 11(2):e331. PubMed ID: 33634979
    [No Abstract]   [Full Text] [Related]  

  • 15. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Status of the COVID-19 Vaccines for Children Age 5 to 11 Years.
    Hageman JR; Alcocer Alkureishi L
    Pediatr Ann; 2021 Nov; 50(11):e444-e445. PubMed ID: 34757881
    [No Abstract]   [Full Text] [Related]  

  • 17. Transitioning to endemicity with COVID-19 research.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2022 Mar; 22(3):297. PubMed ID: 35151377
    [No Abstract]   [Full Text] [Related]  

  • 18. Special focus 'SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics'.
    Dhama K; Singh Malik Y; Rabaan AA; Rodriguez-Morales AJ
    Hum Vaccin Immunother; 2020 Dec; 16(12):2888-2890. PubMed ID: 33393853
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2: vaccines in the pandemic era.
    Li DD; Li QH
    Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.